ENTITY

Aragen Life Sciences Limited (ALS IN)

3
Analysis
Health Care • India
Aragen Life Sciences Limited (ALS) is an India-based, fully integrated contract research, development, and manufacturing organization (CRDMO). ALS offers a diversified platform of solutions across the entire drug lifecycle, which spans from contract discovery and preclinical research to contract development and manufacturing (CDMO) for both small molecules and biologics.
more
•05 Sep 2026 14:02

Aragen Life Sciences Limited (ALS IN): Synthetic Expert Call Transcript (05 Sep 2026)

BIOSECURE Act tailwinds are directionally real but commercially lagged: While WuXi AppTec’s addition to the US Department of Defense's 1260H list...

Share
•04 Sep 2026 13:08

Aragen Life Science Pre-IPO Tearsheet

Aragen Life Sciences Limited (ALS IN) is looking to raise at least US$300m in its upcoming India IPO. The deal will be run by Axis, Citi, GS, JM...

Logo
123 Views
Share
•07 Sep 2026 08:08

Aequitas ECM Weekly (7 September 2026)-Shein, Mech-Mind, Longsys, Jio, Elice, Cathay, Bilibili,

Aequitas Research's weekly update on the IPOs, placements, lockup expiry and other ECM linked events that were covered by the team over the past week.

Logo
153 Views
Share
No more insights
x